Embolism - Clinical trials 

  • Clinical trials

Clinical trials for Embolism

Information provided by WHO International Clinical Trials Registry

The clinical trials below are relevant to Embolism. For all clinical trials, go to clinical trials search

This list shows clinical trials for Embolism

Search result filters
Recruitment status
Trials for children:
Country of trial:

You have searched for the following terms

  • Embolism
Title Recruitment status Location
Comparative Investigation of Low Molecular Weight (LMW) Heparin/Edoxaban Tosylate (DU176b) Versus (LMW) Heparin/Warfarin in the Treatment of Symptomatic Deep-Vein Blood Clots and/or Lung Blood Clots. (The Edoxaban Hokusai-VTE Study). Recruiting United Kingdom
Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruiting United Kingdom
The IMPACT of BIOTRONIK Home Monitoring Guided Anticoagulation on Stroke Risk in Patients With Implanted ICD and CRT-D Devices Recruiting United Kingdom
Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism Recruiting United Kingdom
A randomised parallel group study to compare transarterial particle embolism with percutaneous ethanol injection in patients with unifocal, small (<3cm), non-resectable hepatocellular carcinoma Not recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate (150 mg bid) compared to warfarin (INR 2.0-3.0) for the secondary prevention of venous thromboembolism. RE-MEDY - RE-MEDY Not Recruiting United Kingdom
A Pivotal Study to Evaluate the Safety and Effectiveness of RMT Medical Technology's SafeFlo® Vena Cava Filter Not recruiting United Kingdom
A Phase 3, Active (Warfarin) Controlled, Randomized, Double-Blind, Parallel Arm Study to Evaluate Efficacy and Safety of Apixaban in Preventing Stroke and Systemic Embolism in Subjects with Nonvalvular Atrial Fibrillation + Pharmacogenetics Blood Sample Amendment Number 1 - Site Specific, version 3.0, dated 04-Nov-2006 Revised protocol 04 incorporating Amendments 02, 05, 07, 10 & 11 and Administrative letters 02, 04, 05 & 08 - ARISTOTLE Not Recruiting United Kingdom
A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once Daily Oral Rivaroxaban (BAY 59-7939) With Adjusted-Dose Oral Warfarin for the Prevention of Stroke and Non-Central Nervous System Systemic Embolism in Subjects With Non-Valvular Atrial Fibrillation (39039039AFL3001) Not Recruiting United Kingdom
A phase III, randomised, multicenter, double-blind, parallel-group, active controlled study to evaluate the efficacy and safety of oral dabigatran etexilate 150 mg bid compared to warfarin INR 2.0-3.0 for the secondary prevention of venous thromboembolism RE-MEDY Secondary VTE prevention - RE-MEDY Not Recruiting United Kingdom
  • Link to Directgov – public services all in one place
  • The Information Standard - Certified member